Does Mochi Health Take Insurance? What You'll Actually Pay

Does Mochi Health accept insurance?

The short answer is no for the two charges every Mochi patient pays. The $79 monthly membership and the compounded semaglutide or tirzepatide medication fee are strictly cash-pay, and Mochi says so directly in its own FAQ. There's no code to submit, no claim filed, no copay to negotiate — you pay the listed price regardless of what your plan covers.

Branded medication is where the answer gets more interesting, because Mochi does have a real process for it. If your provider prescribes Wegovy, Zepbound, Ozempic, or Mounjaro instead of a compounded version, Mochi asks for your insurance information and its team will submit a prior authorization request on your behalf, including a letter of medical necessity when one's required. Insurers have 30 days to respond by law, and Mochi says it will help bridge the gap with an interim option while you wait. If the PA clears, your prescription fills at a standard pharmacy under your plan's copay instead of Mochi's cash price; if it's denied, you're back to paying Mochi's branded cash rate outright. What Mochi does not do, in either case, is bill your insurer directly itself — the insurance relationship runs through the pharmacy once a PA clears, not through Mochi's own billing system.

One more wrinkle worth separating out: Mochi also runs a program called Wellness Plus for patients who have qualifying in-network insurance, discounting the membership fee by up to a quarter and adding nutrition and behavioral-health services at no copay. That's real value if you qualify, but it's a membership discount and service bundle — it is not insurance paying for your GLP-1 prescription, and it's easy to conflate the two from how it's marketed.

What you'll actually pay at Mochi, insurance or not

Whether or not a PA ever gets filed, this is the number that matters for budgeting. Mochi restructured its pricing in August 2026, moving away from the flat per-medication rate it used to advertise and toward pricing that scales with your prescribed dose — worth knowing if you've seen an older review quote a single flat number for every dose.

• Membership: $79/mo standard, discounted to $39 for your first month
• Compounded semaglutide: $60 to $99/mo depending on your prescribed dose
• Compounded tirzepatide: $90 to $199/mo depending on your prescribed dose
• Branded Wegovy pill: around $149/mo cash price
• Branded Wegovy pen or Ozempic: around $199/mo cash price
• Branded Zepbound: around $299/mo cash price
• Branded Mounjaro: around $499/mo cash price

Stack the membership onto whichever medication you're prescribed and a compounded-semaglutide patient at a starting dose pays around $139 a month, climbing toward $178 at a maintenance dose. A compounded-tirzepatide patient runs from about $169 up to $278 across the same arc. Branded medication without a successful PA adds the membership on top of whichever cash price above applies — meaningfully more than the compounded track, which is the tradeoff for an FDA-approved product with an actual shot at insurance coverage.

Does FSA or HSA money work at Mochi?

Yes for the membership fee — Mochi accepts FSA and HSA cards directly at checkout, confirmed plainly in its own FAQ. For the medication charge, Mochi's insurance help page goes further and says both the membership and the medication qualify, with support staff able to help you pay by card or prepare documentation afterward.

Treat that as directionally true rather than guaranteed for your specific plan. FSA and HSA eligibility is ultimately set by your plan administrator, not by Mochi, and some administrators want a letter of medical necessity on file for a weight-management prescription before they'll reimburse it — a step that's simple to satisfy with an itemized receipt but easy to miss if you're not expecting to need one. A two-minute call to your administrator before you enroll saves a denied-reimbursement surprise later.

How to get a superbill from Mochi, and what it actually gets you

If you'd rather pay out of pocket now and seek reimbursement later — from your FSA/HSA or, less commonly, from an out-of-network insurance benefit — Mochi will prepare what's called a superbill. Request it through the patient portal or by contacting support after you've started your membership; Mochi describes this as a standard, on-request service rather than something generated automatically at checkout.

A superbill is an itemized receipt coded the way a doctor's office would code a visit — diagnosis and procedure codes, dates of service, provider information — not a claim Mochi files on your behalf. You, or your FSA/HSA administrator, are the one who submits it to the payer, and that payer decides whether and how much to reimburse. For FSA/HSA, that's usually straightforward, since prescribed weight-management care generally qualifies as an eligible expense. For traditional insurance reimbursement of out-of-network care, it's a real option but a genuinely uncertain one — a plan that excludes GLP-1s entirely won't reimburse a compounded version of one just because the claim arrives itemized.

If insurance coverage is the priority, how does Mochi compare to Ro?

Mochi's prior authorization process for branded medication is real, but it's thinner on documented process than a platform built around it. Ro runs a dedicated insurance concierge team that verifies your specific plan, submits the PA paperwork, follows up with the insurer directly, and files an appeal if the first attempt is denied, with a published rough timeline of one to two weeks for a decision. Mochi's own materials describe PA support in more general terms — it will submit the request and cites the standard 30-day insurer response window — without that same level of published process detail.

That doesn't make Mochi's PA help worthless; it means Ro is the more insurance-forward choice if getting Wegovy or Zepbound covered is your main goal, while Mochi's strength sits elsewhere — its ABOM-certified physician network and a lower compounded-medication price floor if a PA doesn't come through on either platform. Worth reading the Ro insurance breakdown alongside this page if coverage odds matter more to you than which platform is cheaper cash-pay.

Is Mochi worth it without insurance, especially in perimenopause?

For most people, yes, with eyes open about the number. Run the compounded semaglutide track without any insurance help and you're looking at roughly $1,668 to $2,136 a year all-in; the tirzepatide track runs about $2,028 to $3,336 a year. Both sit well below cash-pay branded pricing, where Zepbound or Mounjaro without coverage can push the annual total past $4,500 to $6,900 once the membership is added.

For perimenopausal and menopausal patients specifically, the calculation often isn't just about the medication line. Mochi's ABOM-certified physicians are trained in the metabolic shifts — insulin resistance, visceral fat redistribution — that show up alongside declining estrogen, and that clinical fluency is part of what the membership is paying for, not just prescription access. If your plan has a real shot at covering a branded GLP-1, it's worth letting Mochi, or a more insurance-forward platform like Ro, try the paperwork before you commit to a full cash year. If it doesn't, Mochi's compounded pricing is one of the more affordable ways into GLP-1 therapy with real physician oversight behind it.